Revolutionizing infection control in ICUs: photocatalytic binder materials with platinum nanoparticles

We present maintenance-free, spray-applied binder materials that photocatalytically form and permanently adhere uniformly distributed platinum nanoparticles on solid and textile surfaces, enabling instantaneous viral inactivation. Authorized third-party evaluations (Japan Textile Products Quality and Technology Center, September 2021 and April 2024) under ISO 18184:2019 demonstrated 99.97% (1–10^-3.6) reduction for Influenza A and 99.9% (1–10^-3.0) for Feline Calicivirus in 15 s; 99.94% (1–10^-3.2) against SARS-CoV-2 was confirmed in 2021. The binder ensures even nanoparticle formation without agglomerates and durable adhesion, outperforming materials requiring frequent replacement. This approach targets contact surfaces, droplets, and aerosols, complementing but surpassing HEPA filters that lack instant inactivation and impose maintenance burdens. The technology promises improved infection control for ICUs and hospitals, with added benefits in sustainability, cost reduction, and straightforward deployment.

Authors

Institutions

Publication Details

Journal
The Egyptian Journal of Critical Care Medicine
Published
2026-04-06
DOI
https://doi.org/10.1007/s44349-026-00046-4
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Revolutionizing infection control in ICUs: photocatalytic binder materials with platinum nanoparticles

Yoshiyasu Takefuji
The Egyptian Journal of Critical Care Medicine
Nanoplatforms for cancer theranostics
article

Revolutionizing infection control in ICUs: photocatalytic binder materials with platinum nanoparticles

Yoshiyasu Takefuji
article en

Abstract

We present maintenance-free, spray-applied binder materials that photocatalytically form and permanently adhere uniformly distributed platinum nanoparticles on solid and textile surfaces, enabling instantaneous viral inactivation. Authorized third-party evaluations (Japan Textile Products Quality and Technology Center, September 2021 and April 2024) under ISO 18184:2019 demonstrated 99.97% (1–10^-3.6) reduction for Influenza A and 99.9% (1–10^-3.0) for Feline Calicivirus in 15 s; 99.94% (1–10^-3.2) against SARS-CoV-2 was confirmed in 2021. The binder ensures even nanoparticle formation without agglomerates and durable adhesion, outperforming materials requiring frequent replacement. This approach targets contact surfaces, droplets, and aerosols, complementing but surpassing HEPA filters that lack instant inactivation and impose maintenance burdens. The technology promises improved infection control for ICUs and hospitals, with added benefits in sustainability, cost reduction, and straightforward deployment.

The Egyptian Journal of Critical Care MedicineVol. 13(1)
Musashino University (JP)
Openalex Percentile: Top 33%
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.